title: Reply to the Editor-Prognostic Implication of Baseline PR Interval in Patients Undergoing Cardiac Resynchronization Therapy.
authors.affiliation: 1st Dept of Cardiology Medical University of Warsaw Warsaw, Poland.
authors.forename: Łukasz
authors.initials: Ł
authors.lastname: Januszkiewicz
authors.affiliation: Massachusetts General Hospital Boston, Massachusetts.
authors.forename: Eszter
authors.initials: E
authors.lastname: Vegh
authors.affiliation: Massachusetts General Hospital Boston, Massachusetts.
authors.forename: Rasmus
authors.initials: R
authors.lastname: Borgquist
authors.affiliation: Massachusetts General Hospital Boston, Massachusetts.
authors.forename: Abhishek
authors.initials: A
authors.lastname: Bose
authors.affiliation: Massachusetts General Hospital Boston, Massachusetts.
authors.forename: Ajay
authors.initials: A
authors.lastname: Sharma
authors.affiliation: Massachusetts General Hospital Boston, Massachusetts.
authors.forename: Mary
authors.initials: M
authors.lastname: Orencole
authors.affiliation: Massachusetts General Hospital Boston, Massachusetts.
authors.forename: Theofanie
authors.initials: T
authors.lastname: Mela
authors.affiliation: Massachusetts General Hospital Boston, Massachusetts.
authors.forename: Jagmeet P
authors.initials: JP
authors.lastname: Singh
authors.affiliation: VA Healthcare System Boston West Rozbury, Massdachusetts. Electronic address: kimberly1022@gmail.com.
authors.forename: Kimberly A
authors.initials: KA
authors.lastname: Parks
mesh_terms: D002037:Bundle-Branch Block; D058406:Cardiac Resynchronization Therapy; D017147:Defibrillators, Implantable; D006333:Heart Failure; D006801:Humans; D011379:Prognosis; D016896:Treatment Outcome